CHEBI:75416 - EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitor

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitor
ChEBI ID CHEBI:75416
Definition An EC 6.1.* (CO bond-forming ligase) inhibitor that interferes with the action of any ligase forming aminoacyl tRNA and related compounds (EC 6.1.1.*).
Stars This entity has been manually annotated by the ChEBI Team.
ChEBI Ontology
Outgoing EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitor (CHEBI:75416) is a EC 6.1.* (CO bond-forming ligase) inhibitor (CHEBI:76706)
Incoming methioninehydroxamic acid (CHEBI:75415) has role EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitor (CHEBI:75416)
EC 6.1.1.11 (serine—tRNA ligase) inhibitor (CHEBI:75495) is a EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitor (CHEBI:75416)
EC 6.1.1.12 (aspartate—tRNA ligase) inhibitor (CHEBI:82756) is a EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitor (CHEBI:75416)
EC 6.1.1.2 (tryptophan—tRNA ligase) inhibitor (CHEBI:79392) is a EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitor (CHEBI:75416)
EC 6.1.1.4 (leucine—tRNA ligase) inhibitor (CHEBI:77953) is a EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitor (CHEBI:75416)
EC 6.1.1.6 (lysine—tRNA ligase) inhibitor (CHEBI:167677) is a EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitor (CHEBI:75416)
Synonyms Sources
aminoacyl tRNA synthetase inhibitor ChEBI
aminoacyl tRNA synthetase inhibitors ChEBI
EC 6.1.1.* (ligases forming aminoacyl tRNA and related compounds) inhibitors ChEBI
EC 6.1.1.* inhibitor ChEBI
EC 6.1.1.* inhibitors ChEBI
ligases forming aminoacyl tRNA and related compounds (EC 6.1.1.*) inhibitor ChEBI
ligases forming aminoacyl tRNA and related compounds (EC 6.1.1.*) inhibitors ChEBI
tRNA synthetase inhibitor ChEBI
tRNA synthetase inhibitors ChEBI
Last Modified
15 March 2021